source
- Northwest Biotherapeutics' brain cancer therapy faces 931-day delay in UK approvalNorthwest Biotherapeutics, a public biotech developing a brain cancer treatment, filed a marketing application with the UK Medicines and Healthcare products Regulatory Agency (MHRA) in late Decembe…
- FDA issues early alert on non‑sterile BD ChloraPrep applicators in Medline convenience kitsFDA CDRH issued an early alert about a potentially high‑risk device issue involving BD ChloraPrep applicators in Medline convenience kits that may not be sterile. Medline sent a letter on June 12…